1007859-08-6

Basic information

• Product Name: Allyl4-(hydroxymethyl)benzylcarbamate
• Synonyms: Allyl4-(hydroxymethyl)benzylcarbamate;N-[[4-(Hydroxymethyl)phenyl]methyl]carbamic acid 2-propen-1-yl ester;Carbamic acid, N-[[4-(hydroxymethyl)phenyl]methyl]-, 2-propen-1-yl ester
• CAS NO: 1007859-08-6
• Molecular Formula: C₁₂H₁₅NO₃
• Molecular Weight: 221.2524
• Mol File: 1007859-08-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 398.8±37.0 °C(Predicted)
• Appearance: /
• Density: 1.146
• PKA: 12.45±0.46(Predicted)
• CAS DataBase Reference: Allyl4-(hydroxymethyl)benzylcarbamate(CAS DataBase Reference)
• NIST Chemistry Reference: Allyl4-(hydroxymethyl)benzylcarbamate(1007859-08-6)
• EPA Substance Registry System: Allyl4-(hydroxymethyl)benzylcarbamate(1007859-08-6)

Safety Data

• Hazardous Substances Data: 1007859-08-6(Hazardous Substances Data)

Usage

Properties

1. Chemical compound
2. Falls under the category of carbamates
3. Allyl group attached to a benzene ring
4. Hydroxymethyl group present
5. Carbamate functional group present
6. Potential pesticidal and fungicidal properties
7. May have applications in agricultural and industrial settings
8. Possible uses as a chemical intermediate
9. Requires further research for full understanding of potential uses and effects

Category

carbamates

Uses

pesticides, fungicides, herbicides

Structure

allyl group attached to a benzene ring, hydroxymethyl group, carbamate functional group

Upstream product

• 39895-56-2 4-hydroxymethyl-benzylamine 
• 135544-68-2 N-(allyloxycarbonyloxy)succinimide 
• 2937-50-0 Allyl chloroformate 
• 1129-35-7 4-cyanobenzoic acid methyl ester 
• 6232-11-7 methyl 4-(aminomethyl)benzoate hydrochloride 
• 1173157-52-2 C₁₃H₁₅NO₄ 

Downstream Products

• 1007859-13-3 N-[(4-formylphenyl)methyl]prop-2-enyloxycarboxamide 
• 1173158-94-5 N-({4-[(1,3-dioxoisoindolin-2-yloxy)methyl]phenyl}methyl)prop-2-enyloxycarboxamide 
• 1173158-84-3 (2R)-N-methoxy-4-phenyl-2-[({4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}methyl)amino]butanamide 
• 1310450-65-7 (2R)-N-methoxy-4-phenyl-2-[({4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}methyl)amino]butanamide hydrochloric acid salt 
• 1173238-91-9 (2R)-4-phenyl-N-(phenylmethoxy)-2-[({4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}methyl)amino]butanamide 
• 1173158-88-7 (2R)-4-phenyl-N-(phenylmethoxy)-2-[({4-[(prop-2-enyloxycarbonylamino)methyl]phenyl}methyl)amino]butanamide hydrochloride 
• 1173158-95-6 N-({4-[(aminooxy)methyl]phenyl}methyl)prop-2-enyloxycarboxamide 
• 1173158-98-9 (2R)-N-{[4-(aminomethyl)phenyl]methoxy}-2-[(tert-butoxy)carbonylamino]-4-methylpentanamide formic acid salt 
• 1173158-99-0 tert-butyl 2-((2-(((N-((4-(((2R)-2-((tert-butoxy)carbonylamino)-4-methylpentanoylaminooxy)methyl)phenyl)methyl)carbamoyl)methyl)(2-(bis(((tert-butyl)oxycarbonyl)methyl)amino)ethyl)amino)ethyl)(((tert-butyl)oxycarbonyl)methyl)amino)acetate 
• 1173156-53-0 2-{[2-({[N-({4-[((2R)-2-amino-4-methylpentanoylaminooxy)methyl]phenyl}methyl)carbamoyl]methyl}{2-[bis(carboxymethyl)amino]ethyl}amino)ethyl](carboxymethyl)amino}acetic acid trifluoroacetic acid salt 
• 1173159-08-4 tert-butyl 2-{7-[(N-{[4-({(2R)-2-[(tert-butoxy)carbonylamino]-4-methylpentanoylaminooxy}methyl)phenyl]methyl}carbamoyl)methyl]-4,10-bis{[(tert-butyl)oxycarbonyl]methyl}-1,4,7,10-tetraazacyclododecyl}acetate 
• 1173156-62-1 2-(7-{[N-({4-[((2R)-2-amino-4-methylpentanoylaminooxy)methyl]phenyl}methyl)carbamoyl]methyl}-1,4,7,10-tetraaza-4,10-bis(carboxymethyl)cyclododecyl)acetic acid trifluoracetic acid salt 
• 1173157-55-5 N-((4-(bromomethyl)phenyl)methyl)prop-2-enyloxycarboxamide 
• 1173157-59-9 (2R)-N-{[4-(aminomethyl)phenyl]methoxy}-2-[(tert-butoxy)carbonylamino]-4-phenylbutanamide trifluoroacetic acid salt 

Relevant articles and documents

N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter.

N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS

The present disclosure is directed to compounds, diagnostic agents, and related methods. In some cases, methods for treating patients are provided. More specifically, the disclosure provides compounds, diagnostic agents, and kits for detecting and/or imaging and/or monitoring elastin rich tissues. In addition, the disclosure provides methods of detecting and/or imaging and/or monitoring the presence of coronary plaque, carotid plaque, iliac/femoral plaque, aortic plaque, renal artery plaque, plaque of any arterial vessel, aneurism, vasculitis, other diseases of the arterial wall, and/or damage or structural changes in ligaments, uterus, lungs or skin, as indicated by changes in total vessel wall area, internal lumen size, and exterior arterial perimeter.